Erik C. Dreaden

12.5k total citations · 4 hit papers
54 papers, 10.2k citations indexed

About

Erik C. Dreaden is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Erik C. Dreaden has authored 54 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biomedical Engineering, 18 papers in Molecular Biology and 18 papers in Biomaterials. Recurrent topics in Erik C. Dreaden's work include Nanoparticle-Based Drug Delivery (17 papers), Gold and Silver Nanoparticles Synthesis and Applications (15 papers) and RNA Interference and Gene Delivery (12 papers). Erik C. Dreaden is often cited by papers focused on Nanoparticle-Based Drug Delivery (17 papers), Gold and Silver Nanoparticles Synthesis and Applications (15 papers) and RNA Interference and Gene Delivery (12 papers). Erik C. Dreaden collaborates with scholars based in United States, Canada and Singapore. Erik C. Dreaden's co-authors include Mostafa A. El‐Sayed, Xiaohua Huang, Alaaldin M. Alkilany, Catherine J. Murphy, Megan Mackey, Paula T. Hammond, Lauren A. Austin, Vahid Serpooshan, Morteza Mahmoudi and Dennis Brown and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Nucleic Acids Research.

In The Last Decade

Erik C. Dreaden

52 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The golden age: gold nanoparticles for biomedicine

2011 2.8k citations Erik C. Dreaden, Alaaldin M. Alkilany et al. Chemical Society Reviews profile →
Cellular uptake of nanoparticles: journey inside the cell

2017 2.1k citations Shahed Behzadi, Vahid Serpooshan et al. Chemical Society Reviews profile →
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice

2008 948 citations Erin B. Dickerson, Erik C. Dreaden et al. Cancer Letters profile →
Size Matters: Gold Nanoparticles in Targeted Cancer Drug Delivery

2012 501 citations Erik C. Dreaden, Lauren A. Austin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik C. Dreaden United States	28	4.6k	3.5k	3.4k	3.2k	2.7k	54	10.2k
Alaaldin M. Alkilany Jordan	34	5.4k 1.2×	6.4k 1.9×	4.0k 1.2×	3.8k 1.2×	5.2k 1.9×	76	14.0k
Jinhao Gao China	53	5.8k 1.3×	6.3k 1.8×	4.8k 1.4×	2.7k 0.8×	1.5k 0.5×	154	12.2k
Chun Li United States	60	6.6k 1.4×	3.0k 0.9×	4.0k 1.2×	3.8k 1.2×	2.0k 0.7×	255	13.3k
Jesse V. Jokerst United States	48	7.9k 1.7×	3.7k 1.1×	2.6k 0.8×	3.1k 1.0×	1.6k 0.6×	179	12.1k
Miaoxin Yang United States	23	3.2k 0.7×	2.8k 0.8×	1.9k 0.5×	1.6k 0.5×	2.4k 0.9×	45	6.5k
Hongchen Gu China	56	4.0k 0.9×	3.4k 1.0×	2.9k 0.8×	2.5k 0.8×	1.1k 0.4×	208	9.2k
Jie Lü China	48	4.3k 0.9×	5.2k 1.5×	3.7k 1.1×	2.2k 0.7×	927 0.3×	230	11.0k
Pilar Rivera Gil Germany	36	2.5k 0.6×	3.2k 0.9×	2.0k 0.6×	1.8k 0.6×	1.7k 0.6×	72	6.8k
Krishnendu Saha United States	27	3.0k 0.6×	3.3k 0.9×	1.6k 0.5×	3.3k 1.0×	2.2k 0.8×	36	8.0k
Anna Salvati Netherlands	48	4.5k 1.0×	5.0k 1.5×	5.6k 1.6×	4.4k 1.4×	1.3k 0.5×	119	13.8k

Countries citing papers authored by Erik C. Dreaden

Since Specialization

Citations

This map shows the geographic impact of Erik C. Dreaden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik C. Dreaden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik C. Dreaden more than expected).

Fields of papers citing papers by Erik C. Dreaden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik C. Dreaden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik C. Dreaden. The network helps show where Erik C. Dreaden may publish in the future.

Co-authorship network of co-authors of Erik C. Dreaden

This figure shows the co-authorship network connecting the top 25 collaborators of Erik C. Dreaden. A scholar is included among the top collaborators of Erik C. Dreaden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik C. Dreaden. Erik C. Dreaden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Chengjing, Priscilla Do, Greg Gibson, et al.. (2022). B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12. Scientific Reports. 12(1). 11870–11870. 12 indexed citations

Kong, Yi Wen & Erik C. Dreaden. (2022). PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives. Frontiers in Bioengineering and Biotechnology. 10. 879988–879988. 20 indexed citations

Summers, Ryan J., Xiaodong Wang, Stephen V. Frye, et al.. (2021). Therapeutic Targeting of Mertk and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia. Blood. 138(Supplement 1). 1184–1184. 1 indexed citations

Kong, Yi Wen, Erik C. Dreaden, Sandra Morandell, et al.. (2020). Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints. Nature Communications. 11(1). 4124–4124. 24 indexed citations

Correa, Santiago, Natalie Boehnke, Sean G. Smith, et al.. (2020). Tuning Nanoparticle Interactions with Ovarian Cancer through Layer-by-Layer Modification of Surface Chemistry. ACS Nano. 14(2). 2224–2237. 91 indexed citations

Silva, Ana Sofia, Kevin E. Shopsowitz, Santiago Correa, et al.. (2020). Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy. International Journal of Pharmaceutics. 591. 119989–119989. 10 indexed citations

Choi, Ki Young, Santiago Correa, Jouha Min, et al.. (2019). Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer‐by‐Layer Nanoparticles. Advanced Functional Materials. 29(20). 94 indexed citations

Behzadi, Shahed, Vahid Serpooshan, Wei Tao, et al.. (2017). Cellular uptake of nanoparticles: journey inside the cell. Chemical Society Reviews. 46(14). 4218–4244. 2082 indexed citations breakdown →

Correa, Santiago, Erik C. Dreaden, Li Gu, & Paula T. Hammond. (2016). Engineering nanolayered particles for modular drug delivery. Journal of Controlled Release. 240. 364–386. 105 indexed citations

10.

Dreaden, Erik C., Yi Wen Kong, Stephen W. Morton, et al.. (2015). Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle. Clinical Cancer Research. 21(19). 4410–4419. 49 indexed citations

11.

Choi, Jae-Hyeok, Seong‐Oh Kim, Erik C. Dreaden, et al.. (2015). Adsorption of hyaluronic acid on solid supports: Role of pH and surface chemistry in thin film self-assembly. Journal of Colloid and Interface Science. 448. 197–207. 28 indexed citations

12.

Shopsowitz, Kevin E., et al.. (2015). Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells. Nucleic Acids Research. 44(2). 545–557. 10 indexed citations

13.

McCombs, Jessica R., Ying Wang, Joseph T. Paletta, et al.. (2014). Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging. RePEc: Research Papers in Economics. 3 indexed citations

14.

Austin, Lauren A., Megan Mackey, Erik C. Dreaden, & Mostafa A. El‐Sayed. (2014). The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery. Archives of Toxicology. 88(7). 1391–1417. 355 indexed citations

15.

McCombs, Jessica R., Ying Wang, Joseph T. Paletta, et al.. (2014). Redox-responsive branched-bottlebrush polymers for in vivo MRI and fluorescence imaging. Nature Communications. 5(1). 5460–5460. 242 indexed citations

16.

Dreaden, Erik C., et al.. (2012). Small Molecule–Gold Nanorod Conjugates Selectively Target and Induce Macrophage Cytotoxicity towards Breast Cancer Cells. Small. 8(18). 2819–2822. 68 indexed citations

17.

Dreaden, Erik C., Alaaldin M. Alkilany, Xiaohua Huang, Catherine J. Murphy, & Mostafa A. El‐Sayed. (2011). The golden age: gold nanoparticles for biomedicine. Chemical Society Reviews. 41(7). 2740–2779. 2780 indexed citations breakdown →

18.

Dreaden, Erik C., Megan Mackey, Xiaohua Huang, Bin Kang, & Mostafa A. El‐Sayed. (2011). Beating cancer in multiple ways using nanogold. Chemical Society Reviews. 40(7). 3391–3391. 498 indexed citations

19.

Neretina, Svetlana, Erik C. Dreaden, Wei Qian, et al.. (2009). The Dependence of the Plasmon Field Induced Nonradiative Electronic Relaxation Mechanisms on the Gold Shell Thickness in Vertically Aligned CdTe−Au Core−Shell Nanorods. Nano Letters. 9(11). 3772–3779. 16 indexed citations

20.

Dickerson, Erin B., Erik C. Dreaden, Xiaohua Huang, et al.. (2008). Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Letters. 269(1). 57–66. 948 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact